Navigation Links
New Balance Celebrates the 20th Anniversary of Susan G. Komen for the Cure(R) Partnership

BOSTON, Feb. 3 /PRNewswire/ -- New Balance announced today that 2009 marks the company's 20th year as a proud sponsor of Susan G. Komen for the Cure(R). New Balance will celebrate this anniversary with the introduction of a pink special edition New Balance 993 running shoe and an expected $1 million donation to Susan G. Komen for the Cure(R).


"We are extremely proud of our 20-year relationship with Susan G. Komen for the Cure(R) and are committed to finding a cure for breast cancer," says Chris Mann, associate integrated marketing manager for New Balance. "We believe we can reach a large number of consumers and make a significant contribution to breast cancer education and research by promoting physical fitness and healthy lifestyles as a way to reduce the risk of breast cancer."

Anniversary Celebration

As a long-time Susan G. Komen for the Cure(R) partner, New Balance is committed to supporting the mission of Komen for the Cure(R) and raising funds through corporate and consumer donations. In 2009, New Balance will donate up to $1 million (with a guaranteed minimum donation of $500,000) to Susan G. Komen for the Cure(R) from the proceeds of the Lace Up for the Cure(R) Collection.

To celebrate the anniversary, New Balance will debut a special edition 993 running shoe. The 993 is a heritage shoe and is the latest offering from the most enduring technical athletic shoe series in the footwear industry. The special edition 993, an all pink suede shoe, features the Komen for the Cure(R) pink ribbon, an insert adorned with an anniversary logo denoting the twenty-year partnership and a hangtag that details New Balance's commitment to Komen for the Cure(R). All special edition 993s will be manufactured in the U.S. and distributed in a new pink and black anniversary box with matching tissue paper, all featuring the Komen pink ribbon. The box's inside cover explains additional information about New Balance's relationship with Komen. The special edition 993 will debut in August 2009 with a suggested retail price of $140.00.

In July, a limited number of customizable anniversary 993s will be available for purchase. Consumers can personalize the tongue of the shoes with the name of a survivor or loved one and one of the following phrases: "In Honor of", "Running for", or "Lace Up!" Additional details about the customizable 993 program will be released in the coming months.


New Balance has been associated with Susan G. Komen for the Cure(R) since 1989, and has been a National Series Sponsor of the Race for the Cure(R) since 1991 - making New Balance the longest running sponsor of the race series. As a National Series Sponsor, the company partners with retailers and Komen Affiliates across the country to promote awareness at the local level. In addition, the company sponsors the Breast Cancer 3-Day(R) Walk, Marathon for the Cure(R) and Honorary Team New Balance, a group of breast cancer survivors selected from each Komen Race for the Cure(R). In September and October, the company hangs a giant pink ribbon at their global headquarters in Boston, MA to highlight that month's Massachusetts Race for the Cure(R) event and October's Breast Cancer Awareness Month.

Lace Up for the Cure(R) Collection

The 2009 New Balance Lace Up for the Cure(R) footwear, apparel and accessories collection, which is available at retail year-round, includes 4 models of women's athletic shoes from the running, walking and active lifestyle categories. Each shoe features the Susan G. Komen for the Cure(R) pink ribbon logo and an insert with a repeating pattern of the ribbon. The collection is also distinguished by pink ribbon tissue paper in each shoebox and a hang-tag that explains the symbol's significance and the company's 20-year relationship with Komen for the Cure(R). Highlights from the spring 2009 footwear collection include the WW760KM, a fitness walking shoe that provides lightweight cushioning and stability, and the WR769KM, a performance running shoe designed to provide a stable, cushioned ride. The 769 is the official shoe of the Susan G. Komen Race for the Cure(R) and the 760 is the official shoe of the Breast Cancer 3-Day(R). All four shoes in the spring 2009 collection will be available in April 2009.

The spring Lace Up for the Cure(R) collection will also include performance apparel and accessories. The apparel component will feature 25 pieces, including jackets, sports bras and workout pants. New additions to the 2009 collection include the Ventilator Crop, an adjustable sports bra designed for use during medium impact activities, and the Printed Tank, a fun, feminine top that wicks away moisture and protects against UV rays. Accessories include workout bags, performance socks, sunglasses and hats, including the new Reversible Bucket Hat. Similar to the footwear, each apparel and accessory piece in the collection is distinguished by the Komen for the Cure(R) ribbon.

For more information about New Balance's involvement with Susan G. Komen for the Cure(R) or to view the Lace Up for the Cure(R) Collection, please visit

New Balance, headquartered in Boston, MA has the following mission: Demonstrating responsible leadership, we build global brands that athletes are proud to wear, associates are proud to create and communities are proud to host. New Balance employs more than 4000 people around the globe, and in 2007 reported worldwide sales of $1.63 billion. For more information please visit

SOURCE New Balance
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mind out of balance, body out of balance
2. Perception of health and balance has direct impact on walking activity, new study says
3. Smart Balance Presented to the Consumer Analyst Group of New York
4. Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations
5. Keeping a Healthy Holiday Balance
6. Primary Insomnia Tied to Brain Neurochemical Imbalance
7. Natural Hormone Balance: Gaining Ground in the Fight Against Breast Cancer
8. Stem-cell sentry sounds the alarm to maintain balance between cancer and aging, U-M researchers find
9. Smart Balance to Webcast Presentation at Canaccord Adams Global Growth Conference
10. P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth
11. Smart Balance Announces Marketing Organization Appointment
Post Your Comments:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving ... has dropped below 10,000 for the first time since 2011. In 2014, there were ... to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: